Publication
New rules for MDEL holders: Health Canada’s terms and conditions authority
Amendments to the Medical Devices Regulations affecting the regulatory framework for medical device establishment licences (MDEL) are now in effect.
United Kingdom | Publication | December 2021
The DWP is consulting over removing performance-based fees entirely from the 0.75% charge cap that applies to DC default funds. The aim is to further encourage DC schemes to invest in illiquid assets, such as infrastructure, to aid the UK’s economic recovery.
Although new laws were introduced from October allowing trustees to smooth performance fees over a period of 5 years, the Government is concerned these changes do not go far enough. The Productive Finance Working Group (convened by the Bank of England, HM Treasury and the FCA) recently recommended further consideration of the performance fees and charge cap issue and the Chancellor promised another consultation in the autumn budget.
The DWP recognises that there are other barriers to the type of DC investment the Government is keen to promote, such as daily pricing. It accepts that changes to the charge cap alone will not act as a 'silver bullet' for all issues but hopes to remove at least one barrier DC trustees may face.
The consultation closes on January 18, 2022.
Publication
Amendments to the Medical Devices Regulations affecting the regulatory framework for medical device establishment licences (MDEL) are now in effect.
Publication
Early January is a good time to take stock of workplace law developments that arose in 2024, and how those developments may evolve in 2025.
Publication
As you prepare for your next AGM, stay up-to-date on key developments in Canadian corporate and securities legislation, corporate governance guidance and institutional shareholder proxy voting guidelines that may impact the management information circular for your 2025 annual shareholder meeting and your 2025 annual disclosure filings.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025